Archives202520242023202220212020201920182017201620152014201320122011 April 01, 2019Update on Nucant cancer programme Read More March 14, 2019IMM March 2019 Corporate Update Read More December 17, 2018Appointment of NOMAD Read More September 07, 2018IMM September 2018 Corporate Update Read More January 25, 2017Update on Lupuzor™ Pivotal Phase III Study – Full Analysis of Patient Recruitment Read More January 24, 2017Change of Adviser Read More December 22, 2016Update on Lupuzor™ Pivotal Phase III Study – Patient Recruitment Completed Read More November 09, 2016Notification of Major Interest by Legal & General Read More October 26, 2016TR1 Notification of Major Interest Read More October 21, 2016Proposed Accelerated Bookbuild for Vendor Placing and Issue of Equity Read More October 21, 2016Close of Accelerated Bookbuild Read More September 30, 2016INTERIM RESULTS ANNOUNCEMENT for the six months ended 30 June 2016 Read More 1234…8
January 25, 2017Update on Lupuzor™ Pivotal Phase III Study – Full Analysis of Patient Recruitment Read More
December 22, 2016Update on Lupuzor™ Pivotal Phase III Study – Patient Recruitment Completed Read More
